Intrexon (XON) Raises $150 Million Mega-Round
5/2/2013 9:04:12 AM
Staying up-to-date has never been simpler. Sign up for the free
GenePool newsletter today!
Synthetic biology company Intrexon Corp., which has major operations in Germantown, just announced a $150 million mega-financing from both new investors and affiliates of company's own chairman and CEO, "biotech billionaire" Randal J. Kirk. The Blacksburg, Va.-based biotech's new funders, who were not disclosed, contributed the bulk of the Series F round, according to a news release. The cash "will be used to provide working capital for the establishment of additional exclusive channel collaborations in Intrexon's core sectors, including Healthcare, Food, Energy and Environment, continued development of the company's industry-leading technology platforms, expansion of sales and marketing, and research and development."
Help employers find you! Check out all the jobs and post your resume.